Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003994940 | SCV004813607 | pathogenic | Hypophosphatasia | 2024-02-20 | criteria provided, single submitter | clinical testing | Variant summary: The variant involves the deletion of exons 1-12 in the ALPL gene. This deletion includes the entire coding sequence of the gene. As the exact proximal and distal breakpoints are unknown, it may extend beyond the annotated region of the gene to include other flanking genes. A presumed nomenclature of c.(?_-200)_(*763_?)del has been designated for the purposes of this classification. The variant was absent in 21692 control chromosomes (gnomAD). To our knowledge, no occurrence of c.(?_-200)_(*763_?)del in individuals affected with Hypophosphatasia and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 1074110). Based on the evidence outlined above, the variant was classified as pathogenic. |